Osteopontin – a biomarker of disease, but also of stage stratification of the functional myocardial contractile deficit by chronic ischaemic heart disease
Autor: | Gheorghe Manole, Bogdan-Ioan Coculescu, Cristina Mariana Stocheci, Elena Claudia Coculescu, Gabi Valeriu Dincă, Cristina Berteanu |
---|---|
Rok vydání: | 2019 |
Předmět: |
Adult
Male medicine.medical_specialty diastolic heart failure (dhf) Myocardial Ischemia osteopontin (opn) Diastole Disease 01 natural sciences Internal medicine Drug Discovery medicine Humans Osteopontin Stage (cooking) Pharmacology Ejection fraction biology 010405 organic chemistry business.industry lcsh:RM1-950 General Medicine Middle Aged medicine.disease Myocardial Contraction preserved ejection fraction 0104 chemical sciences 010404 medicinal & biomolecular chemistry lcsh:Therapeutics. Pharmacology Clinical research Heart failure Chronic Disease biology.protein Cardiology biomarker Biomarker (medicine) Female business Biomarkers Research Paper |
Zdroj: | Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 34, Iss 1, Pp 783-788 (2019) Journal of Enzyme Inhibition and Medicinal Chemistry |
ISSN: | 1475-6374 1475-6366 |
Popis: | The study analyses the significance of the plasmatic values of the OPN dosed to 91 people suffering from diastolic cardiac dysfunction with preserved ejection fraction, thus revealing significant growths of its level compared to the normal value. Despite being a clinical research, its conclusions are a breakthrough, differing from the results of other studies published in the relevant medical literature. We can make this assertion because this study analyses the clinical information given by the circulating values of the OPN, based on experimental models (animals), or on patients with congestive heart failure, which can be identified with the existence of a low systolic flow. The results of our study allow us to assert that the plasmatic values of this glycoprotein lead to its acceptance in the medical practice as a new biomarker that provides indicators regarding the stratification of risk with the patients suffering from heart failure of the diastolic dysfunction type, but whose systolic flow is preserved. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |